Zaleha M I, Osman A, Iskandar Z A, Sazali S, Ali M M, Roslan I, Khalid B A
Department of Community Health and Department of Medicine, Medical Faculty, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Asia Pac J Clin Nutr. 1998 Jun;7(2):138-50.
In order to study the effect of levothyroxine in the treatment of endemic goitre, a longitudinal study was conducted among the Aborigines in Lanai Post and Sinderut Post, situated in an iodine-deficient area located in the district of Kuala Lipis, Pahang. All subjects in the treatment group (Lanai Post) were given 100 µg of levothyroxine per day and were followed for 1 1/2 years. A total of 311 subjects were examined at baseline, 323 on the first, 256 on the second, 239 on the third and 184 on the fourth visit following levothyroxine supplementation. Goitre prevalence, thyroid hormones, thyroid volume, nutritional status, urinary iodine levels, arterial blood pressure and mental performance were determined. Following the intervention, goitre prevalence was significantly reduced in the treatment group (baseline 42.8% vs final visit 13.0%, p<0.0001); however, no significant difference was noted in the control group. Total T4 levels were increased in the treatment group (p<0.0001), while a significant reduction was noted in the control group (p<0.0001). Thyroid-stimulating hormone levels increased significantly in the treatment group following 1 year of intervention, while no significant changes were observed in the control group. As for the thyroid volume, both groups showed a significant increment following the intervention (p<0.0001). With respect to the nutritional status, the treatment group showed a significant increase in body weight following the intervention (p<0.05). In addition, the mid-arm circumference and body mass index also increased after 1 year of intervention. However, the control group showed a reduction in the waist-hip ratio (p<0.0001). Although there was no statistical difference in the waist-hip ratio in the treatment group, there has been a significant reduction observed after 1 year of intervention. At 1 year, a reduction in skinfold thickness was noted in the treatment group while only the triceps and subscapular were increased in the control group. The body fat was decreased in the treatment group following 1 year of intervention (p<0.0001). No particular trend was noted in the urinary iodine excretion in the treatment group, but surprisingly, the levels were increased in the control group (p<0.0001). A significant increase in both systolic and diastolic blood pressures was observed in the treatment group following 1 year of intervention, but the controls showed a reduction in the systolic blood pressure (p<0.0001). Both groups showed a remarkable increase in mental performance, with a more pronounced effect in the treatment group (p<0.05). The correction of iodine deficiency by levothyroxine supplementation has a short-term beneficial effect in reducing the prevalence of goitre and improving the mental ability among the Aborigines in endemic areas; however, proper monitoring and close supervision are needed to maintain compliance.
为研究左甲状腺素治疗地方性甲状腺肿的效果,在彭亨州瓜拉立卑县一个碘缺乏地区的拉奈村和辛德鲁村的原住民中开展了一项纵向研究。治疗组(拉奈村)的所有受试者每天服用100μg左甲状腺素,并随访1年半。补充左甲状腺素后,共有311名受试者在基线期接受检查,323名在第一次随访时接受检查,256名在第二次随访时接受检查,239名在第三次随访时接受检查,184名在第四次随访时接受检查。测定了甲状腺肿患病率、甲状腺激素、甲状腺体积、营养状况、尿碘水平、动脉血压和智力表现。干预后,治疗组的甲状腺肿患病率显著降低(基线期为42.8%,末次随访时为13.0%,p<0.0001);然而,对照组未观察到显著差异。治疗组的总T4水平升高(p<0.0001),而对照组显著降低(p<0.0001)。干预1年后,治疗组的促甲状腺激素水平显著升高,而对照组未观察到显著变化。至于甲状腺体积,两组在干预后均显著增大(p<0.0001)。关于营养状况,治疗组在干预后体重显著增加(p<0.05)。此外,干预1年后,上臂中部周长和体重指数也有所增加。然而,对照组的腰臀比降低(p<0.0001)。虽然治疗组的腰臀比无统计学差异,但干预1年后观察到显著降低。干预1年后,治疗组的皮褶厚度减小,而对照组仅肱三头肌和肩胛下皮褶厚度增加。干预1年后,治疗组的体脂减少(p<0.0001)。治疗组的尿碘排泄未观察到特定趋势,但令人惊讶的是,对照组的尿碘水平升高(p<0.0001)。干预1年后,治疗组的收缩压和舒张压均显著升高,但对照组的收缩压降低(p<0.0001)。两组的智力表现均显著提高,治疗组的效果更明显(p<0.05)。补充左甲状腺素纠正碘缺乏对降低地方性甲状腺肿患病率和提高地方性甲状腺肿流行地区原住民的智力有短期有益作用;然而,需要进行适当监测和密切监督以维持依从性。